[Prise en charge pharmacologique de la BPCO: Un éventail de produits pour insuffler une bouffée d'air].

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Canadian family physician Medecin de famille canadien

• Publication date

  2016-05-01

• Fields of study

  Not labeled

• Identifiers
  PMID 27255633PMCID PMC4865352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.

  2015cited by this paper
• Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.

  2013cited by this paper
• Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment?

  2013cited by this paper
• Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.

  2013cited by this paper
• Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.

  2012cited by this paper
• Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD

  2012cited by this paper
• Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease.

  2012cited by this paper
• Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.

  2012cited by this paper
• Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.

  2011cited by this paper
• Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

  2011cited by this paper
• Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease

  2010cited by this paper
• Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis

  2009cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• COPD-related morbidity and mortality after smoking cessation: status of the evidence

  2008cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

  2005cited by this paper
• Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary Care

  2003cited by this paper
• Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003.

  2003cited by this paper
• Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease

  1999cited by this paper

• No citing papers are available for this paper.